High RAS-RAF binding as assessed via proximity ligation assay is associated with sensitivity to KRASG12C inhibitors in NSCLC

被引:0
|
作者
Kato, Ryoji
Solanki, Hitendra S.
Imbody, Denis
Majumder, Anurima
Stern, Yaakov
Bridenstine, Liznair
Gundlapalli, Harika
Aronchik, Ida
Johnson, Joseph
Haura, Eric B.
机构
关键词
D O I
10.1158/1535-7163.TARG-23-B006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B006
引用
收藏
页数:2
相关论文
共 5 条
  • [1] RAS:RAF proximity ligation assay may predict response to KRASG12C inhibitors in NSCLC
    Kato, Ryoji
    Solanki, Hitendra S.
    Imbody, Denis
    Majumder, Anurima
    Stern, Yaakov
    Bridenstine, Liznair
    Johnson, Joseph
    Haura, Eric B.
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [2] In Situ RAS:RAF Binding Correlates with Response to KRASG12C Inhibitors in KRASG12C-Mutant Non-Small Cell Lung Cancer
    Kato, Ryoji
    Solanki, Hitendra S.
    Ozakinci, Hilal
    Desai, Bina
    Gundlapalli, Harika
    Yang, Yu Chi
    Aronchik, Ida
    Singh, Mallika
    Johnson, Joseph
    Marusyk, Andriy
    Boyle, Theresa A.
    Haura, Eric B.
    CLINICAL CANCER RESEARCH, 2025, 31 (06) : 1150 - 1162
  • [3] TEAD Inhibitors Sensitize KRASG12C Inhibitors via Dual Cell Cycle Arrest in KRASG12C-Mutant NSCLC
    Tammaccaro, Salvina Laura
    Prigent, Philippe
    Le Bail, Jean-Christophe
    Dos-Santos, Odette
    Dassencourt, Laurent
    Eskandar, Myriam
    Buzy, Armelle
    Venier, Olivier
    Guillemot, Jean-Claude
    Veeranagouda, Yaligara
    Didier, Michel
    Spanakis, Emmanuel
    Kanno, Tokuwa
    Cesaroni, Matteo
    Mathieu, Stephane
    Canard, Luc
    Casse, Alhassan
    Windenberger, Fanny
    Calvet, Loreley
    Noblet, Laurence
    Sidhu, Sukhvinder
    Debussche, Laurent
    Moll, Jurgen
    Valtingojer, Iris
    PHARMACEUTICALS, 2023, 16 (04)
  • [4] Development of a biotin-streptavidin-enhanced enzyme-linked immunosorbent assay (BA-ELISA) for high-throughput screening of KRASG12C inhibitors
    Liu, Shuang
    Shi, Junfen
    Li, Hongjuan
    Li, Jijun
    Zhu, Yan
    Li, Binghui
    Sun, Yinghui
    SLAS DISCOVERY, 2022, 27 (02) : 107 - 113
  • [5] De Novo Rational design of peptide-based covalent inhibitors via mapping of complementary binding site residues – technical protocol and case study on KRASG12C and BTK481C
    Ernest Oduro-Kwateng
    Musab Ali
    Ibrahim Oluwatobi Kehinde
    Li Rao
    Mahmoud E. S. Soliman
    BMC Methods, 2 (1):